Autor: "Sarker SJ" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Dose-dense chemotherapy for untreated poor-prognosis and relapsed germ-cell tumours: an 18-year experience with GAMEC chemotherapy.
Autorzy:: Shamash J; Department of Medical Oncology, St Bartholomew's Hospital, London, UK.
Mee M; Department of Medical Oncology, St Bartholomew's Hospital, London, UK.
Sarker SJ; Department of Medical Oncology, St Bartholomew's Hospital, London, UK.
Wilson P; Department of Medical Oncology, St Bartholomew's Hospital, London, UK.
Ansell W; Department of Medical Oncology, St Bartholomew's Hospital, London, UK.
Greenwood M; Department of Medical Oncology, St Bartholomew's Hospital, London, UK.
Berney D; Department of Histopathology, St Bartholomew's Hospital, London, UK.
Alifrangis C; Department of Medical Oncology, St Bartholomew's Hospital, London, UK.; Department of Medical Oncology, University College London Hospital, London, UK.; Pokaż więcej
Źródło:: BJU international [BJU Int] 2020 Jun; Vol. 125 (6), pp. 843-852. Date of Electronic Publication: 2020 May 04.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Agents/*administration & dosage
Brain Neoplasms/*drug therapy
Neoplasms, Germ Cell and Embryonal/*drug therapy
Testicular Neoplasms/*drug therapy
Adolescent ; Adult ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols ; Brain Neoplasms/diagnosis ; Brain Neoplasms/mortality ; Humans ; Male ; Middle Aged ; Neoplasms, Germ Cell and Embryonal/diagnosis ; Neoplasms, Germ Cell and Embryonal/mortality ; Neoplasms, Germ Cell and Embryonal/pathology ; Prognosis ; Retrospective Studies ; Testicular Neoplasms/diagnosis ; Testicular Neoplasms/mortality ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinoma.
Autorzy:: Crusz SM; Barts Cancer Institute, Queen Mary University of London, London, UK.
Tang YZ; Department of Radiology, St Bartholomews Hospital, London, UK.
Sarker SJ; Barts Cancer Institute, Queen Mary University of London, London, UK.
Prevoo W; Departments of Surgical and Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Kiyani I; Institute of Nuclear Medicine, University College Hospital, London, UK.
Beltran L; Department of Surgery, Whipps Cross Hospital, London, UK.
Peters J; Department of Surgery, Whipps Cross Hospital, London, UK.
Sahdev A; Department of Radiology, St Bartholomews Hospital, London, UK.
Bex A; Departments of Surgical and Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Powles T; Barts Cancer Institute, Queen Mary University of London, London, UK.
Gerlinger M; Centre for Evolution and Cancer, The Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK. .; The Royal Marsden Hospital, London, UK. .; Pokaż więcej
Źródło:: BMC medicine [BMC Med] 2016 Nov 14; Vol. 14 (1), pp. 185. Date of Electronic Publication: 2016 Nov 14.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Renal Cell/*drug therapy
Kidney Neoplasms/*drug therapy
Protein Kinase Inhibitors/*therapeutic use
Adult ; Aged ; Carcinoma, Renal Cell/enzymology ; Carcinoma, Renal Cell/genetics ; Carcinoma, Renal Cell/pathology ; Disease Progression ; Female ; Humans ; Kidney Neoplasms/enzymology ; Kidney Neoplasms/genetics ; Kidney Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Metastasis ; Prospective Studies ; Retrospective Studies ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Comment on 'Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer'.
Autorzy:: Shamash J; St Bartholomew's Hospital, 7th Floor, Gloucester House, Little Britain, UK.
Sarker SJ; Centre for Experimental Cancer Medicine, Queen Mary University of London, London, UK.; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2014 Jan 07; Vol. 110 (1), pp. 266-7. Date of Electronic Publication: 2013 Dec 03.
Typ publikacji:: Letter; Comment
MeSH Terms:: Androstenols/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Diethylstilbestrol/*therapeutic use
Estrogens, Non-Steroidal/*therapeutic use
Prostatic Neoplasms/*drug therapy
Steroid 17-alpha-Hydroxylase/*antagonists & inhibitors
Humans ; Male

Opinia redakcyjna

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Significant decline in Galactomannan Signal during storage of clinical serum samples.
Autorzy:: Johnson GL; Blizard Institute of Cell and Molecular Science, Queen Mary University of London, London E1 2AT, UK. .
Sarker SJ
Hill K
Tsitsikas DA
Morin A
Bustin SA
Agrawal SG; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2013 Jun 24; Vol. 14 (7), pp. 12970-7. Date of Electronic Publication: 2013 Jun 24.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Bronchoalveolar Lavage Fluid*
Invasive Pulmonary Aspergillosis*
Aspergillosis/diagnosis ; Humans ; Retrospective Studies ; Sensitivity and Specificity

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Smaller sample sizes for phase II trials based on exact tests with actual error rates by trading-off their nominal levels of significance and power.
Autorzy:: Khan I; Cancer Research UK and UCL Cancer Trials Centre, University College London, 90 Tottenham Court Road (fifth floor), London, UK. />Sarker SJ
Hackshaw A; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2012 Nov 20; Vol. 107 (11), pp. 1801-9.
Typ publikacji:: Journal Article
MeSH Terms:: Clinical Trials, Phase II as Topic*
Research Design*
Sample Size*
Neoplasms/*therapy
Humans ; Randomized Controlled Trials as Topic